44 related articles for article (PubMed ID: 21958292)
1. Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
Castellano S; Kuck D; Viviano M; Yoo J; López-Vallejo F; Conti P; Tamborini L; Pinto A; Medina-Franco JL; Sbardella G
J Med Chem; 2011 Nov; 54(21):7663-77. PubMed ID: 21958292
[TBL] [Abstract][Full Text] [Related]
2. Rapid synthesis of new DNMT inhibitors derivatives of procainamide.
Halby L; Champion C; Sénamaud-Beaufort C; Ajjan S; Drujon T; Rajavelu A; Ceccaldi A; Jurkowska R; Lequin O; Nelson WG; Guy A; Jeltsch A; Guianvarc'h D; Ferroud C; Arimondo PB
Chembiochem; 2012 Jan; 13(1):157-65. PubMed ID: 22170584
[TBL] [Abstract][Full Text] [Related]
3. Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches.
Lanka G; Banerjee S; Adhikari N; Ghosh B
Mol Divers; 2024 Apr; ():. PubMed ID: 38637479
[TBL] [Abstract][Full Text] [Related]
4. O-H bond activation of β,γ-unsaturated oximes
Yi L; Zhu C; Chen X; Yue H; Ji T; Ma Y; Cao Y; Kancherla R; Rueping M
Chem Sci; 2023 Dec; 14(48):14271-14279. PubMed ID: 38098711
[TBL] [Abstract][Full Text] [Related]
5. DNA Methyltransferase 3A: A Significant Target for the Discovery of Inhibitors as Potent Anticancer Drugs.
Feng Q; Duan H; Zhou X; Wang Y; Zhang J; Zhang H; Chen G; Bao X
Mini Rev Med Chem; 2024; 24(5):507-520. PubMed ID: 37642180
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.
Cho CC; Lin CJ; Huang HH; Yang WZ; Fei CY; Lin HY; Lee MS; Yuan HS
ACS Chem Biol; 2023 Jun; 18(6):1335-1350. PubMed ID: 37188336
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in DNA methyltransferase inhibitors as anticancer agents.
Zhang Z; Wang G; Li Y; Lei D; Xiang J; Ouyang L; Wang Y; Yang J
Front Pharmacol; 2022; 13():1072651. PubMed ID: 37077808
[TBL] [Abstract][Full Text] [Related]
8. Nitrile Oxide, Alkenes, Dipolar Cycloaddition, Isomerization and Metathesis Involved in the Syntheses of 2-Isoxazolines.
Krompiec S; Lodowski P; Kurpanik-Wójcik A; Gołek B; Mieszczanin A; Fijołek A; Matussek M; Kaszuba K
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985520
[TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu
Kaczorowska K; Stankiewicz A; Bugno R; Paluchowska MH; Burnat G; Brański P; Cieślik P; Wierońska JM; Milik M; Nowak M; Przybyłowicz A; Kozioł A; Hogendorf A; Hogendorf AS; Kalinowska-Tłuścik J; Duszyńska B; Pilc A; Bojarski AJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768302
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of DNA Methylation.
Lopez M; Gilbert J; Contreras J; Halby L; Arimondo PB
Adv Exp Med Biol; 2022; 1389():471-513. PubMed ID: 36350520
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel chiral spiro-β-lactams from nitrile oxides and 6-(
Alves AJS; Silvestre JAD; Pinho E Melo TMVD
RSC Adv; 2022 Oct; 12(48):30879-30891. PubMed ID: 36349033
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties.
Li E; Wang K; Zhang B; Guo S; Xiao S; Pan Q; Wang X; Chen W; Wu Y; Xu H; Kong X; Luo C; Chen S; Liu B
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1537-1555. PubMed ID: 35670075
[TBL] [Abstract][Full Text] [Related]
13. In vitro and molecular docking and analysis of isoxazoline derivatives with DPPH.
Geetha C; Rajakumar PR
Bioinformation; 2020; 16(11):807-816. PubMed ID: 34803253
[TBL] [Abstract][Full Text] [Related]
14. [2 + 2 + 1] Cycloaddition of
Ma L; Jin F; Cheng X; Tao S; Jiang G; Li X; Yang J; Bao X; Wan X
Chem Sci; 2021 Jul; 12(28):9823-9830. PubMed ID: 34349956
[No Abstract] [Full Text] [Related]
15. Expanding the Structural Diversity of DNA Methyltransferase Inhibitors.
Juárez-Mercado KE; Prieto-Martínez FD; Sánchez-Cruz N; Peña-Castillo A; Prada-Gracia D; Medina-Franco JL
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33375520
[TBL] [Abstract][Full Text] [Related]
16. Beyond regulations at DNA levels: A review of epigenetic therapeutics targeting cancer stem cells.
Zhang S; Gong Y; Li C; Yang W; Li L
Cell Prolif; 2021 Feb; 54(2):e12963. PubMed ID: 33314500
[TBL] [Abstract][Full Text] [Related]
17. QSAR-driven rational design of novel DNA methyltransferase 1 inhibitors.
Phanus-Umporn C; Prachayasittikul V; Nantasenamat C; Prachayasittikul S; Prachayasittikul V
EXCLI J; 2020; 19():458-475. PubMed ID: 32398970
[TBL] [Abstract][Full Text] [Related]
18. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation.
Zwergel C; Fioravanti R; Stazi G; Sarno F; Battistelli C; Romanelli A; Nebbioso A; Mendes E; Paulo A; Strippoli R; Tripodi M; Pechalrieu D; Arimondo PB; De Luca T; Del Bufalo D; Trisciuoglio D; Altucci L; Valente S; Mai A
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32075099
[TBL] [Abstract][Full Text] [Related]
19. Cycloaddition Strategies for the Synthesis of Diverse Heterocyclic Spirocycles for Fragment-Based Drug Discovery.
King TA; Stewart HL; Mortensen KT; North AJP; Sore HF; Spring DR
European J Org Chem; 2019 Sep; 2019(31-32):5219-5229. PubMed ID: 31598091
[TBL] [Abstract][Full Text] [Related]
20. Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.
Milite C; Amendola G; Nocentini A; Bua S; Cipriano A; Barresi E; Feoli A; Novellino E; Da Settimo F; Supuran CT; Castellano S; Cosconati S; Taliani S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1697-1710. PubMed ID: 31537132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
